The Chemours Company: A Brand-New Opportunity for Investors

investchronicle 14

The Chemours Company kicked off the trading day on 08/14/19 with a price decrease of -4.44%, equivalent to -$0.56 relative change for the day. Taking a more long-term approach, CC had a 52-week range of $12.33 to $46.13. At the time of this article’s publishing, this stock is trading at $12.04 after starting the trading session at $12.14. Moving on, the stock has demonstrated a 52-week change amounting to 237.47, alongside an S&P500 52-Week Change of 186.03. At the time of writing, this stock’s 50-day Moving Average stands at $20.10, while the 200-day Moving Average of this stock is currently $29.72.

Currently, this company’s share volume is sitting at $3,215,307, but has maintained average daily volume of $3.20M. This stock has generated an average Year to Date volume of $2.43 million, alongside an average 20-day volume of $4.07 million. This publicly-traded company’s shares outstanding now amounts to $177.68 million, simultaneously with a float of $162.04 million. The organization now has a market capitalization sitting at $2.14 billion.

The Chemours Company(CC) Ownership Data

Now let’s turn our focus to how large-scale investors are behaving with this stock. The Chemours Company’s current insider ownership accounts for 0.60%, in contrast to 83.60% institutional ownership. According to the most recent latest insider trade that took place on Aug 07 this organization’s Director bought 1,790 at the rate of 13.99, making the entire transaction hit 25,042 in total value, affecting insider ownership by 36,018. Preceding that transaction, on Aug 06 Company’s President – Titanium Tech bought 12,000 at a price of 13.77, making the whole transaction’s value amount to 165,240. This particular insider is now the holder of 117,774 in total.

If we take a glance at the Ownership summary of The Chemours Company’s stock, 581 Institutional holders make up 76.26% of its total stock ownership. All together, they are the legal holders of 124,671,094 shares, which are valued at about $1,570,855,784 in total. If we focus on the top 3 stockholders for this publicly-traded organization, FMR LLC owns 23.62 million shares, with VANGUARD GROUP INC in 2nd place owning 16.85 million shares and BLACKROCK INC. in third place with total ownership of 16.11 million shares.

The Chemours Company (CC) Earnings and Revenue Data

In the latest quarterly report that this company released, which was put into the public domain on Mar-19, the organization reported $0.63 earnings per share (EPS) for the three-month period, surpassing the consensus estimate (set at $0.90) by $0.27.

The corporation racked down revenue of $1,464.00million for the previous financial quarter, compared to the mean analyst estimate of $1,513.88 million. This company achieved a net margin of 12.60 while generating a return on equity of 79.52. The Chemours Company’s full-quarter revenue decreased by -20.46%, when compared against the year-ago quarter. Wall Street market experts anticipate that the next fiscal year will bring earnings of 1.26 per share during the current fiscal year.

The Chemours Company’s EPS increase for this current 12-month fiscal period is 31.30%, and is forecasted to reach 58.25% in the upcoming year. Looking at the long run, market analysts have predicted that Company’s EPS will increase by 1.50% through the next 5 years, which can be compared against the 18.20% growth it accomplished over the previous five years trading on the market.

Additional Trading Performance Indicators

Now turning our attention to the current performance indicators for The Chemours Company, this organization’s Quick Ratio in the last reported quarter now stands at 1.10. The company has managed to achieve an average true range (ATR) of 1.07. Alongside those, its PE Ratio stands at $3.56, and its Beta score is 2.47.

Another valuable indicator worth considering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 0.36 for this organization. Plus, this company’s price to book ratio for the last three-month fiscal period reported is 2.40, whereas its price to cash per share for the last quarter landed at 3.55.

In the same vein, CC’s Diluted EPS (Earnings per Share) trailing twelve month was posted at 3.38, a figure that is expected to reach 0.67 in the next reported quarter, and analysts expect it will be 58.25% at the market close of one year from today’s date.